A new publication, led by Dr Ed Emmott, details proteolysis of viral and cellular proteins in the context of viral infection, and informs the development of targeted strategies to inhibit SARS-CoV-2 and treat COVID-19.
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential